Recently, the winners of two highly anticipated awards in the domestic capital market — the "Most Valuable Listed Company Golden Bull Award" and the "China Listed Company Value Awards" — were announced. Baheal Medical (301015.SZ) stood out among thousands of listed companies, winning the titles of "Most Valuable Investment Golden Bull Award 2023" and "Top 50 GEM Listed Companies by Value." These accolades highlight the capital market's strong recognition of the company's exceptional performance, value return capabilities, and growth potential.

On September 27, 2024, Xuanwu Hospital of Capital Medical University held its 2024 Medical Education and Research Conference. During the event, Baheal Pharma Group and Xuanwu Hospital signed a strategic cooperation agreement to jointly establish the "Xuanwu-Baheal Pharma Neurological Disease Collaborative Innovation Laboratory" and the "Xuanwu-Baheal Pharma Thoracic Disease Joint Laboratory." The collaboration aims to advance cutting-edge medical research and the translation of scientific achievements in key areas such as neuroscience and thoracic surgery. The signing ceremony was attended by Guan Zhongjun, Party Secretary of Xuanwu Hospital, Zhao Guoguang, Deputy Party Secretary and President of Xuanwu Hospital, Fu Gang, Chairman of Baheal Pharma Group, and Song Qing, Director and President of Baheal Pharma Group.

Shanghai Huanghai Pharmaceutical Co., Ltd. (referred to as Shanghai Huanghai Pharma), a subsidiary of Baheal Pharmaceutical Co., Ltd. (referred to as Baheal Pharma), has been honored with the 2024 Excellence in Pharmaceutical Quality Award at the recent 2nd Pharmaceutical High-Quality Development Industry Conference and China Pharmaceutical Managers Annual Meeting. This award is a recognition of Shanghai Huanghai Pharma's outstanding quality management system and superior product quality.

On September 21, 2024, the "Collaborative Innovation and Health Future" Summit Forum, part of the 2024 World Chinese Doctors Annual Conference, took place in Qingdao. Hosted by the World Association of Chinese Doctors and co-organized by Baheal Pharma Group, the event marked the Association's 10th anniversary. As a highlight of the conference's opening ceremony, the "World Association of Chinese Doctors--Baheal Research Achievement Transformation Base" was officially signed and unveiled, witnessed by all attendees.

Baheal Medical (301015.SZ) was recently named on the "2024 China Emerging Pharmaceutical Innovators" list at the 41st National Pharmaceutical Industry Information Conference, hosted by the China National Pharmaceutical Industry Information Center...